Header cover image
  • Investing Ideas
  • /
  • Swedish Pharmaceuticals & Biotech Dividend Powerhouses (3%+ Yield)

Swedish Pharmaceuticals & Biotech Dividend Powerhouses (3%+ Yield)

Results

1

0 new

This screener pinpoints dividend all-stars that boast strong fundamentals with yields typically exceeding 3%.

1 companies

BioGaia

Market Cap: SEK 10.6b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

BIOG B

SEK 104.90

7D

6.9%

1Y

-13.1%